Perifosine in Treating Patients With Recurrent Prostate Cancer
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of perifosine in treating patients who have
recurrent prostate cancer. Drugs used in chemotherapy such as perifosine use different ways
to stop tumor cells from dividing so they stop growing or die